NeuraStasis develops StrokeGuard, a wearable emergency device designed for rapid, non-invasive neuroprotection during acute stroke transport. This device uses closed-loop trigeminal nerve stimulation to increase cerebral blood flow by adapting to the patient's hemodynamic state. StrokeGuard aims to preserve salvageable brain tissue by bridging the gap between stroke onset and definitive hospital-based treatment.
Funding
$250K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Stroke survivors often face limited access to effective rehabilitation therapies, particularly beyond the initial six-month post-stroke period, hindering their potential for functional recovery and independence. Current rehabilitation approaches may not fully address the complex neurological deficits resulting from stroke, leaving many individuals with persistent disabilities.
Solution
NeuraStasis is developing a non-invasive wearable neurostimulation device designed to enhance stroke recovery by targeting the trigeminal and vagus nerves. The device delivers proprietary electrical stimulation, timed to synchronize neurotransmitter release with increased cerebral blood flow, activating brain networks associated with attention and learning. This approach aims to extend the window of neuroplasticity and promote functional improvements beyond traditional rehabilitation timelines. The device is designed for use in both clinical and home settings, complementing existing therapies to improve patient outcomes and independence.
Target Audience
The primary target audience includes stroke survivors seeking to improve their functional recovery, as well as clinicians and therapists involved in stroke rehabilitation.
Features
- Non-invasive wearable device for convenient application
- Proprietary electrical stimulation of the trigeminal and vagus nerves
- Synchronized neurotransmitter release and increased cerebral blood flow
- Activation of brain networks associated with attention and learning
- Designed for use at home or in clinical settings
- Potential to extend rehabilitation beyond the traditional six-month post-stroke window